Creative Medical Technology Holdings Inc (CELZ) - News Archive

PHOENIX, July 2025 Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology firm focused on regenerative medicine, has announced significant developments in the prevention and treatment...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is making waves in the health and wellness sector with its innovative approaches to reproductive health and pain management. The company is garnering attention n...

In an exciting advancement for the field of regenerative medicine, Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has announced a significant milestone in its ADAPT clinical trial. As of November 13, 2024, th...

In a strategic move to bolster its innovative healthcare initiatives, Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), announced on October 23, 2024, that it has successfully entered into definitive securities...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), an innovative biotechnology company specializing in regenerative therapies, has recently embarked on a groundbreaking initiative. The company announced the deve...

Medical Technology Holdings Inc has been making strides within the healthcare sector, progressing from a total return on investment (ROI) ranking of 2927 in the fourth quarter of 2023 to 2767 in the Mar 31, 2024, quarte...

Creative Medical Technology Announces Breakthrough in iPSCelz Program: Successful Generation of Human Insulin-Producing Islet CellsCreative Medical Technology Holdings, a prominent biotechnology company specializing in...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a leading biotechnology company specializing in regenerative approaches to various medical fields, recently released a corporate update in connection with the f...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a renowned player in biotech innovation, has made a significant breakthrough in the battle against Type 1 Diabetes Mellitus (T1D). Recently, the company has gai...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has recently received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its innovative therapy, CELZ-101, also known as ImmCelzTM. Thi...